345 related articles for article (PubMed ID: 28695313)
1. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Elias RM; Moysés RMA
Int Urol Nephrol; 2017 Oct; 49(10):1815-1821. PubMed ID: 28695313
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease.
Costa TEM; Lauar JC; Innecchi MLR; Coelho VA; Moysés RMA; Elias RM
Int Urol Nephrol; 2022 Sep; 54(9):2255-2261. PubMed ID: 35099689
[TBL] [Abstract][Full Text] [Related]
3. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.
Ennis JL; Worcester EM; Coe FL; Sprague SM
J Nephrol; 2016 Feb; 29(1):63-70. PubMed ID: 25736620
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
[TBL] [Abstract][Full Text] [Related]
5. Association between Parathyroid Hormone, 25 (OH) Vitamin D, and Chronic Kidney Disease: A Population-Based Study.
Wang WH; Chen LW; Lee CC; Sun CY; Shyu YC; Hsu HR; Chien RN; Wu IW
Biomed Res Int; 2017; 2017():7435657. PubMed ID: 28367447
[TBL] [Abstract][Full Text] [Related]
6. The influence of renal function on vitamin D metabolism in the very elderly.
Van Pottelbergh G; Matheï C; Vaes B; Adriaensen W; Gruson D; Degryse JM
J Nutr Health Aging; 2013 Feb; 17(2):107-11. PubMed ID: 23364486
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease population.
Ngai M; Lin V; Wong HC; Vathsala A; How P
Clin Nephrol; 2014 Oct; 82(4):231-9. PubMed ID: 25161115
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
[TBL] [Abstract][Full Text] [Related]
9. Secondary Hyperparathyroidism in Patients with Biliopancreatic Diversion After 10 Years of Follow-up, and Relationship with Vitamin D and Serum Calcium.
Alejo Ramos M; Cano Rodríguez IM; Urioste Fondo AM; Pintor de la Maza B; Barajas Galindo DE; Fernández Martínez P; González Herráez L; González de Francisco T; Ballesteros Pomar MD
Obes Surg; 2019 Mar; 29(3):999-1006. PubMed ID: 30523538
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine.
Bureo JC; Arévalo JC; Antón J; Adrados G; Jiménez Morales JL; Robles NR;
Endocrinol Nutr; 2015; 62(7):300-5. PubMed ID: 26138703
[TBL] [Abstract][Full Text] [Related]
11. Serum vitamin D in obese and overweight subjects according to estimated glomerular filtration rate.
Kitsos A; Dounousi E; Kalaitzidis R; Challa A; Siamopoulos KC; Tigas S
Hormones (Athens); 2018 Jun; 17(2):237-246. PubMed ID: 29858844
[TBL] [Abstract][Full Text] [Related]
12. Combined Effects of Vitamin D Status, Renal Function and Age on Serum Parathyroid Hormone Levels.
Niculescu DA; Deacu LG; Caragheorgheopol A; Popescu N; Ghemigian A; Procopiuc C; Rosca R; Poiana C
Front Endocrinol (Lausanne); 2021; 12():657991. PubMed ID: 33995282
[TBL] [Abstract][Full Text] [Related]
13. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
[TBL] [Abstract][Full Text] [Related]
14. Relationships of serum 25-hydroxyvitamin D, ionized calcium and parathyroid hormone after obesity surgery.
Hewitt S; Aasheim ET; Søvik TT; Jahnsen J; Kristinsson J; Eriksen EF; Mala T
Clin Endocrinol (Oxf); 2018 Mar; 88(3):372-379. PubMed ID: 29235126
[TBL] [Abstract][Full Text] [Related]
15. Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice.
Madsen CM; Jørgensen HL; Lind B; Ogarrio HW; Riis T; Schwarz P; Duus BR; Lauritzen JB
Injury; 2012 Jul; 43(7):1052-7. PubMed ID: 22261083
[TBL] [Abstract][Full Text] [Related]
16. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
[TBL] [Abstract][Full Text] [Related]
17. Relationships with serum parathyroid hormone in old institutionalized subjects.
Stein MS; Flicker L; Scherer SC; Paton LM; O'Brien ML; Walton SC; Chick P; Di Carlantonio M; Zajac JD; Wark JD
Clin Endocrinol (Oxf); 2001 May; 54(5):583-92. PubMed ID: 11380488
[TBL] [Abstract][Full Text] [Related]
18. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
Boudville NC; Hodsman AB
Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
[TBL] [Abstract][Full Text] [Related]
19. Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.
Cooper K; Quarles D; Kubo Y; Tomlin H; Goodman W
Nephron Clin Pract; 2012; 121(3-4):c124-30. PubMed ID: 23208191
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone response to different vitamin D levels in population-based old and very-old Polish cohorts.
Wyskida M; Owczarek AJ; Chełmecka E; Szczerbowska I; Mossakowska M; Grodzicki T; Puzianowska-Kuźnicka M; Olszanecka-Glinianowicz M; Chudek J
Exp Gerontol; 2019 Nov; 127():110735. PubMed ID: 31520697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
